Researchers studying feline immunodeficiency virus, which does not infect humans, and HIV, which is similar, found that an FIV protein can induce an immune response that targets human HIV-infected cells. The findings suggest a novel approach for development of an HIV vaccine for humans. "We found that one particular peptide region on FIV activated the patients' T cells to kill the HIV," said lead researcher Janet Yamamoto, a professor of retroviral immunology at the University of Florida College of Veterinary Medicine.

Related Summaries